VIR
Vir Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.45B
P/E Ratio
—
EPS
$-3.13
Beta
1.64
52W High
$11.66
52W Low
$4.16
50-Day MA
$9.50
200-Day MA
$7.38
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
4.27
PEG Ratio
—
About Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $65.50M |
| Gross Profit (TTM) | $-371.20M |
| EBITDA | $-451.05M |
| Operating Margin | 459241.00% |
| Return on Equity | -47.70% |
| Return on Assets | -24.80% |
| Revenue/Share (TTM) | $0.47 |
| Book Value | $5.49 |
| Price-to-Book | 1.77 |
| Price-to-Sales (TTM) | 22.17 |
| EV/Revenue | 16.33 |
| EV/EBITDA | 0.90 |
| Quarterly Earnings Growth (YoY) | 58.50% |
| Quarterly Revenue Growth (YoY) | 417.80% |
| Shares Outstanding | $168.65M |
| Float | $128.78M |
| % Insiders | 6.59% |
| % Institutions | 81.43% |
Historical Volatility
HV 10-Day
54.76%
HV 20-Day
50.71%
HV 30-Day
53.35%
HV 60-Day
52.57%
HV Rank
16.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($21.56 target)
3
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026